Company Overview and News

0
Great Ajax Corp (AJX) CEO Lawrence Mendelsohn on Q2 2018 Results - Earnings Call Transcript

2018-08-11 seekingalpha
Good afternoon, everyone, and welcome to the Great Ajax Corporation Second Quarter 2018 Financial Results Conference Call. [Operator Instructions]. Please also note, today's event is being recorded. At this time, I'd like to turn the conference call over to Mr. Lawrence Mendelsohn, CEO. Sir, please go ahead.
AJX AJXA

19
Top 50 High Yield Real Estate WallStars Show Gains To 89.2% For August 2019

2018-08-08 seekingalpha
WallStars show positive broker target price upsides. IRSA Propiedades flaunted top net gains, while Orchid Island Capital showed the highest yield.
GEO LMRK ANH ORC ASHFP CHMI CIM TWO AJXA IRCP NRZ SIR JCAP AHT GMRE AHT.WI MFO DX LMRKO MFA LMRKP GNL CLNY IRS AJX

0
17
5 Russell 3000 Top Dogs Fetch >24% Net Gains Per Brokers To July 2019

2018-07-18 seekingalpha
"All Russell US Indexes are subsets of the Russell 3000 Index, [namely] large-cap Russell 1000 & small-cap Russell 2000 Indexes. These Indexes are. building blocks of financial-products [and] performance-benchmarks." - FTSE Russell.
SNH ANH ORC CHMI CIO AJXA NRZ JCAP SLD SLDA WSR LB STWD.WI CYORP GMRE SNHNL SNHNI PEGI DX SFL ARR GNL IVR CLNY PEG STWD AJX

41
Top 50 High Yield Real Estate Issues Show Gains To 42.6% By June 2019

2018-06-29 seekingalpha
Landmark Infrastructure flaunted top net gains, while Orchid Island Capital had highest yield. Top ten gainers, IVR, TWO,WSR, ORC, EARN, NRZ, DX, CHMI, AJX, & LMRK ranged 10.6%-42.6% 6/28/18.
NYMTO ORC CHMI NYMTP EARN TWO AGNC AJXA NRZ DX NLY CYS IVR NYMT AJX

36
5 Russell 3000 Top Dogs Exceed 15% Target Net Gains To June 2019

2018-06-11 seekingalpha
"All Russell US Indexes are subsets of the Russell 3000 Index, [namely] large-cap Russell 1000 & small-cap Russell 2000 Indexes. These Indexes are. building blocks of financial-products [and] performance-benchmarks."---ftserussell.com.
ANH NYMTO ORC STWD.WI CHMI NYMTP GMRE TWO AJXA PEGI NRZ DX NLY CYS PEG NYMT STWD AJX

65
Top 51 Real Estate WallStars Flaunt Yields To 12.2% And Target Gains To 111.3% By May 2019

2018-05-29 seekingalpha
IRSA Propiedades led by net gains, while Two Harbors led by yield. Top ten gainers, GLPI, AJX, BPY, RESI, HASI, APTS, LMRK, CLNS, IRS, & IRCP gains ranged 17.8%-111.3% 5/25/18.
SLDA LMRK ANH ABRN CIM TWO AJXA ABR CLNS NRZ DX GLPI ARR ABRN.CL IVR AJX

3
AJX / Great Ajax Corp. FORM 8-K (Current Report)

2018-05-27 sec.gov
UNITED STATES SECURITIE
AJX

46
50 Russell 3000 Stocks Yield 7.34% To 14.96% For May

2018-05-08 seekingalpha
"All Russell US Indexes are subsets of the Russell 3000 Index, [namely] large-cap Russell 1000 & small-cap Russell 2000 Indexes. These Indexes are. building blocks of financial-products [and] performance-benchmarks."---ftserussell.com.
SLDA NYMTO ORC STWD.WI CHMI NYMTP GMRE TWO AGNC AJXA PEGI NRZ NLY CYS SIR GNL PEG NYMT STWD AJX

6
Great Ajax's (AJX) CEO Larry Mendelsohn on Q1 2018 Results - Earnings Call Transcript

2018-05-02 seekingalpha
Good afternoon and welcome to the Great Ajax Corporation's First Quarter 2018 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions]. Please note, this event is being recorded.
AJX FNMA AJXA

4
Great Ajax Corp 2018 Q1 - Results - Earnings Call Slides

2018-05-01 seekingalpha
The following slide deck was published by Great Ajax Corp in conjunction with their 2018 Q1 earnings call.
AJX AJXA

3
5
AJX / Great Ajax Corp. DEFINITIVE PROXY STATEMENT

2018-04-06 sec.gov
tv490543-def14a - none - 1.9951938s TABLE OF CONTENTS
AJX

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

CUSIP: 38983D300